Non-alcoholic fatty liver disease, not elsewhere classified (Q86648): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| (One intermediate revision by the same user not shown) | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 12:05, 15 August 2026
Primary NAFLD is associated with insulin resistance. Secondary NAFLD is associated with many conditions such as polycystic ovary syndrome, endocrine diseases, sleep apnoea and pancreato-duodenal resection, etc. Steatogenic medications are not included as a cause of NAFLD.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_1331941447 |
||
| English | Non-alcoholic fatty liver disease, not elsewhere classified |
Primary NAFLD is associated with insulin resistance. Secondary NAFLD is associated with many conditions such as polycystic ovary syndrome, endocrine diseases, sleep apnoea and pancreato-duodenal resection, etc. Steatogenic medications are not included as a cause of NAFLD. |
Statements
CID11:ID_1331941447
0 references
dki-india-ID_1331941447
0 references
Concluído
0 references
13 August 2026
0 references
